Abstract

BackgroundPlasmodium vivax infections in humans or in new world monkeys pose research challenges that necessitate the use of alternative model systems. Plasmodium cynomolgi is a closely related species that shares genetic and biological characteristics with P. vivax, including relapses. Here, the haematological dynamics and clinical presentation of sporozoite-initiated P. cynomolgi infections in Macaca mulatta (rhesus macaques) are evaluated over a 100-day period.MethodsFive M. mulatta were inoculated with 2000 P. cynomolgi B strain sporozoites. Parasitological and haematological data were collected daily to study the clinical presentations of primary infections and relapses. Peripheral blood and bone marrow aspirates were collected at specific time points during infection for future and retrospective systems biology analyses.ResultsPatent infections were observed between days 10 and 12, and the acute, primary infection consisted of parasitaemias ranging from 269,962 to 1,214,842 parasites/µl (4.42–19.5 % parasitaemia). All animals presented with anaemia, ranging from moderate (7–10 g/dl) to severe (<7 g/dl), based on peripheral haemoglobin concentrations. Minimum haemoglobin levels coincided with the clearance of parasites and peripheral reticulocytosis was evident at this time. Mild thrombocytopaenia (<150,000 platelets/µl) was observed in all animals, but unlike haemoglobin, platelets were lowest whenever peripheral parasitaemia peaked. The animals’ conditions were classified as non-severe, severe or lethal (in one case) based upon their clinical presentation. The lethal phenotype presented uniquely with an exceptionally high parasitaemia (19.5 %) and lack of a modest reticulocyte release, which was observed in the other animals prior to acute manifestations. One or two relapses were observed in the four surviving animals, and these were characterized by significantly lower parasitaemias and minimal changes in clinical parameters compared to pre-infection values.ConclusionsRhesus macaque infections initiated by P. cynomolgi B strain sporozoites recapitulated pathology of human malaria, including anaemia and thrombocytopaenia, with inter-individual differences in disease severity. Importantly, this study provides an in-depth assessment of clinical and parasitological data, and shows that unlike the primary infections, the relapses did not cause clinical malaria. Notably, this body of research has provided experimental plans, large accessible datasets, and blood and bone marrow samples pertinent for ongoing and iterative systems biology investigations.Electronic supplementary materialThe online version of this article (doi:10.1186/s12936-016-1480-6) contains supplementary material, which is available to authorized users.

Highlights

  • Plasmodium vivax infections in humans or in new world monkeys pose research challenges that neces‐ sitate the use of alternative model systems

  • Plasmodium falciparum is responsible for the largest number of cases and malaria-associated deaths, with extensive research efforts focused on understanding the basic biology and associated pathogenesis of this parasite species

  • RFa14 and RMe14 developed recrudescent infections 48–72 h later, as anticipated based on prior experience with sub-curative artemether treatments of P. cynomolgi and P. coatneyi in rhesus macaques at the Centers for Disease Control and Prevention (CDC) and the Yerkes National Primate Research Center (YNPRC) [43]

Read more

Summary

Introduction

Plasmodium vivax infections in humans or in new world monkeys pose research challenges that neces‐ sitate the use of alternative model systems. Nothing is known about the biology of relapse infections despite the fact that relapses are thought to be responsible for as high as 96 % of vivax infections in different parts of the world [11]. It is currently unclear how relapses are similar or different from primary infections, from a parasitological and clinical perspective, and the relative contribution of relapses to clinical malaria has been uncertain

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.